Cancer screening of healthy volunteers using whole-body 18F-FDG-PET scans: The Nishidai clinic study

European Journal of Cancer

Volumn 43, Issue 12, 2007, Pages 1842-1848

  Kojima, Shinsuke ^a,c   Zhou, Bin ^a,c   Teramukai, Satoshi ^a,c   Hara, Akiko ^b   Kosaka, Noboru ^b   Matsuo, Yoshitomo ^b   Suzuki, Hitoshi ^b   Torigoe, Soichiro ^b   Suzuki, Takayuki ^b   Uno, Kimiichi ^b   Fukushima, Masanori ^a,c  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b Nishidai Clinic Diagnostic Imaging Center   (Japan)

^c Translational Research Informatics Center   (Japan)

Author keywords

18F fluorodeoxyglucose (FDG); Cancer prevention; Cancer screening; Positron emission tomography (PET); Screening and surveillance

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BREAST; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER SCREENING; COLON; DIAGNOSTIC PROCEDURE; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG; MALE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE; SENSITIVITY AND SPECIFICITY; THYROID GLAND; TIME SERIES ANALYSIS; WHOLE BODY SCINTISCANNING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS;

EID: 34547776799     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.05.010     Document Type: Article

References (22)

1. Rohren E.M., Turkington T.G., and Coleman R.E. Clinical applications of PET in oncology. Radiology 231 (2004) 305-332
2. Nakamoto Y. Clinical application of FDG-PET for cancer diagnosis. Nippon Igaku Hoshasen Gakkai Zasshi 63 (2003) 285-293 Article in Japanese
3. Yasuda S., Ide M., Fujii H., et al. Application of positron emission tomography imaging to cancer screening. Br J Cancer 83 (2000) 1607-1611
4. Kao C.H., Kwan A.S., Kwan J.K., et al. The role of 18F-fluorodeoxyglucose positron emission tomography in cancer screening - a preliminary report. Oncol Rep 8 (2001) 1145-1148
5. Shen Y.Y., Su C.T., Chen G.J., et al. The value of 18F-fluorodeoxyglucose positron emission tomography with the additional help of tumour markers in cancer screening. Neoplasma 50 (2003) 217-221
6. Chen Y.K., Ding H.J., Su C.T., et al. Application of PET and PET/CT imaging for cancer screening. Anticancer Res 24 (2004) 4103-4108
7. Executive office of PET Summer Seminar website: The list of PET institutes in Japan. 〈Available: http://pet.jrias.or.jp/index.cfm/28,367,95,html〉; [Nov.29.2005] [Article in Japanese].
8. Wardwell N.R., and Massion P.P. Novel strategies for the early detection and prevention of lung cancer. Semin Oncol 32 (2005) 259-268
9. Quon A., and Gambhir S.S. FDG-PET and beyond: molecular breast cancer imaging. J Clin Oncol 23 (2005) 1664-1673
10. Pastorino U., Bellomi M., Landoni C., et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 362 (2003) 593-597
11. Higashi K., Ueda Y., Seki H., et al. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma. J Nucl Med 39 (1998) 1016-1020
12. Higashi K., Ueda Y., Sakuma T., et al. Comparison of [(18)F]FDG PET and (2 0 1)Tl SPECT in evaluation of pulmonary nodules. J Nucl Med 42 (2001) 1489-1496
13. Avril N., Schelling M., Dose J., et al. Utility of PET in Breast Cancer. Clin Positron Imaging 2 (1999) 261-271
14. Pijl M.E., Chaoui A.S., Wahl R.L., et al. Radiology of colorectal cancer. Eur J Cancer 38 (2002) 887-898
15. Mandel J.S., Bond J.H., Church T.R., et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328 (1993) 1365-1371
16. Smith R.A., Cokkinides V., and Eyre H.J. American Cancer Society: American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin 53 (2003) 27-43
17. Kang K.W., Kim S.K., Kang H.S., et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab 88 (2003) 4100-4104
18. Schoder H., and Yeung H.W. Positron emission imaging of head and neck cancer, including thyroid carcinoma. Semin Nucl Med 34 (2004) 180-197
19. Schoder H., and Larson S.M. Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med 34 (2004) 274-292
20. Japanese Society of Nuclear Medicine; Board for promoting Clinical PET: Guidelines concerning the use of PET for cancer screening. Japanese Journal of Nuclear Medicine 2004;41:1-21. [Article in Japanese].
21. Kojima S, Inubushi M, Ozawa F, et al. Cancer screening trial using whole-body 18F-FDG-PET scan in healthy subjects - Hamamatsu Medical Imaging Center study. Journal of Clinical Oncology 2005 ASCO Annual Meeting Proceedings 2005; 23: No. 16S, Part I of II (June 1 Supplement): 1022.
22. S. Nishizawa, M. Inubushi, H. Okada, et al. Cancer screening trial to evaluate the efficacy of FDG-PET in healthy subjects: 2-year results of the Hamamatsu Medical Imaging Center study. Journal of Clinical Oncology 2006 ASCO Annual Meeting Proceedings Part I. 2006; 24: No. 18S (June 20 Supplement): 1025.